[Renhe Pharmaceutical Co., Ltd.: net profit in 2022 dropped 13.62% compared with the same period last year. 10 yuan]. According to the annual report of Renhe Pharmaceutical Co., Ltd., operating income reached 5.153 billion yuan in 2022, an increase of 4.41% over the same period last year. Net profit was 574 million yuan, down 13.62% from the same period last year. Basic earnings per share is 0.41 yuan; the company plans to pay a cash dividend of 2 yuan (including tax) for every 10 shares.